Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-595-7 | CAS number: 7647-01-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Not specified; published in 1986
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- Experimental procedures for GPMT are not reported in details (minor reporting deficiencies). Purity and source of test material not reported. Individual animal data not reported. The study however included adequate positive controls, and (in the form of a ring study) appeared repeatable at multiple laboratories.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- not applicable
- Principles of method if other than guideline:
- Method: Mouse Ear Swelling Test (MEST) AND Guinea Pig Maximization Test (GPMT)
In a study carried out to validate an alternative dermal sensitization test, female mice were inducted by receiving intradermal injections of FCA (day 0 only) plus topical applications of hydrochloric acid (1% in 70% ethanol) in the stomach area previously clipped free of fur and tape-stripped up to a glossy appearance of the skin (days 0, 1, 2 and 3). Challenge was done applying hydrochloric acid (5% in 70% ethanol) to the left ear, the right one receiving the vehicle alone. Swelling of the ears were measured using a micrometer 24 and 48 hours after application and comparing the results obtained in concurrent control animals. GPMT was also carried out in 15 guinea pigs. - GLP compliance:
- no
- Remarks:
- GLP was not compulsory at the time the study was conducted.
- Type of study:
- other: Mouse Ear Swelling Test AND Guinea Pig Maximization Test
- Justification for non-LLNA method:
- STudy happened to0 be available. With this data available there is no need to perform additionally an LLNA study.
- Species:
- other: female mouse and guinea pigs
- Strain:
- other: mouse: CF-1; strain of guinea pigs not specified
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Sex: mice: female; guinea pigs: sex not specified.
- Source: mice: Charles River or Harlan Sprague-Dawley or Buckshire Corporation. Source of guinea pigs not specified
- Age at study initiation: mice: 6-8 weeks. Age of guiea pigs not specified.
- Weight at study initiation: not specified
- Housing: not specified
- Diet (e.g. ad libitum): not specified
- Water (e.g. ad libitum): not specified
- Acclimation period: mice: 7 days. Guinea pigs: not specified.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): not specified
- Humidity (%): not specified
- Air changes (per hr): not specified
- Photoperiod (hrs dark / hrs light): not specified
IN-LIFE DATES: not specified - Route:
- intradermal and epicutaneous
- Vehicle:
- other: ethanol
- Concentration / amount:
- GPMT:
Intradermal injection, topical induction and challenge: 1% in ethanol
MEST:
Induction: 1% in 70% ethanol
Challenge: 5% in 70% ethanol - Route:
- epicutaneous, occlusive
- Vehicle:
- other: ethanol
- Concentration / amount:
- GPMT:
Intradermal injection, topical induction and challenge: 1% in ethanol
MEST:
Induction: 1% in 70% ethanol
Challenge: 5% in 70% ethanol - No. of animals per dose:
- 10-15 mice, and 5-10 mice for concurrent control group. Guinea pigs not specified.
- Details on study design:
- Both a Mouse Ear Swelling Test (MEST) and traditional GPMT test was conducted. Each of these tests is described separately below.
GPMT:
RANGE FINDING TESTS:
Not specified.
MAIN STUDY
Experimental procedures for the GPMT are not reported in details.
Induction and challenge was conducted with 1% in ethanol.
MEST:
RANGE FINDING TESTS:
The concentrations used in MEST were chosen on the basis of irritation potential. Two mice were used in each of four groups induced and challenged at four different concentrations. Dosages used in the actual validation study were those minimally or non-irritating to the stomach area (for induction), non-irritating to the ear (challenge).
Ten different strains of mice were investigated to determine which were useful or not, and if there were a most sensitive strain. Male and female mice of different ages were tested to determine if there were a difference in sensitivity between the sexes, and what range of age was the most appropriate. Data reported refers to the final test design.
MAIN STUDY:
- Induction: 1% in 70% ethanol
- Challenge: 5% in 70% ethanol (no rechallenge)
- Control group: yes
- Evaluation (hr after challenge): 24 and 48 hours after application
Days -7 to 0 Quarantine/acclimation period
Days 0 to 4 Induction stage
Day 0
- fur of abdomen is clipped
- intradermal injection of FCA (two injections totalling 0.05 mL into the stomach area)
- abdomen skin is tape stripped (up to present a glossy appearance)
- topical application of 100 μL of test substance (or vehicle)
- abdominal skin site is dried rapidly (electric drier)
Days 1, 2 and 3
- abdomen skin is tape stripped (up to present a glossy appearance)
- topical application of 100 μL of test substance (or vehicle)
- abdominal skin site is dried rapidly (electric drier)
Day 10 Challenge stage (same procedure for both treated and control animals)
- topical application of 20 μL of test substance to the left ear
- topical application of 20 μL of vehicle to the right ear
- both ears are dried rapidly
Days 11 and 12 Ear thickness measurement using an “Oditest” D1000 micrometer. Animal maintained under light ether anaesthesia. - Challenge controls:
- yes: vehicle.
- Positive control substance(s):
- yes
- Remarks:
- MEST: Positive controls during development/optimization: 1-chloro-2,4-dinitrochlorobenzene, 2-phenyl-4 ethoxymethylene oxazolone and toluene diisocyanate. 72 substances were tested in the validation test, including these positive controls
- Concentration:
- Not applicable
- No. of animals per dose:
- Not applicable
- Details on study design:
- Not applicable
- Statistics:
- Not applicable
- Positive control results:
- Not specified, but the study included adequate positive controls, and (in the form of a ring study) appeared repeatable at multiple laboratories.
- Parameter:
- SI
- Remarks on result:
- other: Not applicable.
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: Not applicable.
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information
- Conclusions:
- Hydrochloric acid does not posses any sensitizing potential both at MEST and GPMT.
Reference
MEST:
No difference in swelling compared to control was noted in treated mice (100% swelling).
Hydrochloric
acid resulted to be not a sensitizer.
GPMT: 0% sensitized animals.
Summary of results and discussion:
No difference in swelling compared to control was noted in treated mice (100% swelling).
No guinea pig showed a positive sensitisation reaction (0/15) in the GPMT.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
- Migrated from Short description of key information:
Hydrochloric acid does not possess any sensitizing potential both at MEST and GPMT.
Justification for selection of skin sensitisation endpoint:
Only report available.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
- Additional information:
Hydrochloric acid has not shown sensitizing potential in both MEST and GPMT. Lack of sensitising potential is also demonstrated in a HRIPT (Human Repeat Insult Patch Test - see 7.10.4 Sensitisation data (humans))
As chemical respiratory sensitisers also elicit positive results in predictive tests for contact sensitisation, a negative outcome for dermal sensitisation is also predictive for non respiratory sensitisation of the substance.
Migrated from Short description of key information:
HCl is not a respiratory sensitiser.
Justification for selection of respiratory sensitisation endpoint:
At present, recognised and validated animal models for the testing of respiratory hypersensitivity are not available.
Justification for classification or non-classification
Skin: not sensitising - conclusive but not sufficient for classification
Respiratory: not sensitising
Based on the test findings in an MEST and GPMT and in accordance to Regulation (EC) No 1272/2008, HCl does not have to be classified as a skin and respiratory sensitizer.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.